Cme (CME) Return on Equity (2009 - 2026)

Cme (CME) has 18 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.0%, up 48.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (up 48.0% YoY), and the FY2025 annual result was 0.0%, up 35.0% from the prior year.
• Return on Equity climbed to 0.0% in Q1 2026 per CME's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Equity peaked at 1.27% in Q4 2022 and troughed at 0.65% in Q3 2024.
• A 5-year average of 0.1% and a median of 0.0% in 2025 frame the typical range for Return on Equity.
• The sharpest annual moves came in 2022 and 2023: Return on Equity soared 127 bps in 2022, then sank 157 bps in 2023.
• A 5-year view of Return on Equity shows it stood at 1.27% in 2022, then slumped by 124 bps to 0.31% in 2023, then tumbled by 42 bps to 0.44% in 2024, then soared by 100 bps to 0.0% in 2025, then climbed by 8 bps to 0.0% in 2026.
• Business Quant data shows CME's Return on Equity at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.